Impact of the Bioconversion Process to Increase the Yield of Camptothecin (CPT)

Abstract

Background: One of the leading causes of death is cancer. So, there is a continuing need for the development of novel, reasonably priced, and efficiently acting natural anticancer medications. Camptothecins, which are produced from the bark of the divided Camptotheca acuminata plant, are among of the most effective anti-cancer medications that attack different cell types.Objective: Bioconversion is the ability of microorganisms to modify a wide variety of organic compounds to produce useful products. In this paper, they will explain how biotransformation can be helpful to increase the yield of Camptothecin from its resources similar to the process of cortisone production from Rhizopus nigricans which played a vital role in reducing the price of cortisone. This chemical product is a natural and very potent anti-cancer medication.Methods: DNA, RNA, or protein sequences can be arranged using sequence alignments to find related areas: may result from relationships that are structural, functional, or evolutionary. Three or more sequences are involved in multiple sequence alignments. Placing homologous positions of homologous sequences in the same column is the aim of multiple sequence alignments.Results: The active component is mostly found in sections of young plants that undergo photosynthesis. Although the alignment result is not very high, Endophytic fungi are a source of camptothecin indicates that biotransformation of Camptotheca acuminate is feasible if the fungi are properly cultivated. Conclusion: For obtaining the maximum and effective yield of camptothecin, this method has a number of advantages over chemical production. These benefits include the rations' region- and/or stereo-specificity and the processes' eco-friendliness.